UBS Group’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $22.3M | Buy |
|
|||||
|
2025
Q2 | $19.1M | Sell |
|
|||||
|
2025
Q1 | $24.9M | Sell |
|
|||||
|
2024
Q4 | $19.5M | Sell |
|
|||||
|
2024
Q3 | $15.6M | Buy |
|
|||||
|
2024
Q2 | $9.25M | Sell |
|
|||||
|
2024
Q1 | $7.98M | Sell |
|
|||||
|
2023
Q4 | $9.65M | Buy |
|
|||||
|
2023
Q3 | $2.97M | Buy |
|
|||||
|
2023
Q2 | $3.61M | Sell |
|
|||||
|
2023
Q1 | $4.01M | Sell |
|
|||||
|
2022
Q4 | $5.39M | Buy |
|
|||||
|
2022
Q3 | $131K | Sell |
|
|||||
|
2022
Q2 | $576K | Sell |
|
|||||
|
2022
Q1 | $1.46M | Sell |
|
|||||
|
2021
Q4 | $4.82M | Buy |
|
|||||
|
2021
Q3 | $2.71M | Buy |
|
|||||
|
2021
Q2 | $244K | Sell |
|
|||||
|
2021
Q1 | $2.29M | Buy |
|
|||||
|
2020
Q4 | $415K | Sell |
|
|||||
|
2020
Q3 | $229K | Buy |
|
|||||
|
2020
Q2 | $125K | Sell |
|
|||||
|
2020
Q1 | $668K | Buy |
|
|||||
|
2019
Q4 | $383K | Sell |
|
|||||
|
2019
Q3 | $1.54M | Buy |
|
|||||
|
2019
Q2 | $1.86M | Buy |
|
|||||
|
2019
Q1 | $203K | Sell |
|
|||||
|
2018
Q4 | $1.49M | Buy |
|
|||||
|
2018
Q3 | $226K | Buy |
|
|||||
|
2018
Q2 | $486K | Sell |
|
|||||
|
2018
Q1 | $2.9M | Buy |
|
|||||
|
2017
Q4 | $616K | Sell |
|
|||||
|
2017
Q3 | $1.37M | Buy |
|
|||||
|
2017
Q2 | $186K | Buy |
|
|||||
|
2017
Q1 | $171K | Buy |
|
|||||
|
2016
Q4 | $50K | Buy |
|
|||||
|
2016
Q3 | $54K | Sell |
|
|||||
|
2016
Q2 | $48K | Sell |
|
|||||
|
2016
Q1 | $101K | Sell |
|
|||||
|
2015
Q4 | $897K | Buy |
|
|||||
|
2015
Q3 | $182K | Buy |
|
|||||
|
2015
Q2 | $110K | Sell |
|
|||||
|
2015
Q1 | $110K | Sell |
|
|||||
|
2014
Q4 | $135K | Buy |
|